Transaktionen anzeigen
Healthcare

Protalix BioTherapeutics, Inc. has completed a private stock placement

Protalix BioTherapeutics, Inc. has raised funds to refinance the company for further development.

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received the approval of the US Food and Drug Administration, for the treatment of Gaucher disease.

Oaklins’ team in Israel advised Protalix BioTherapeutics, Inc. and acted as a member in the distributors’ consortium.

Art der transaktion
Finanzierung, Fremdkapitalberatung & ECM
BETEILIGTE PARTEIEN

Sprechen Sie mit dem Deal-Team

 Ruben  Eblagon

Ruben Eblagon

Principal

Tel Aviv, Israel
Oaklins Rosario
 Boaz  Levi

Boaz Levi

Partner

Tel Aviv, Israel
Oaklins Rosario
 Olga  Geyber

Olga Geyber

Assistant to Executive Board

Tel Aviv, Israel
Oaklins Rosario

Transaktionen

Iofina secures new debt refinancing
Energy

Iofina secures new debt refinancing

Iofina Plc has refinanced its entire debt by entering into a new loan agreement with First Financial Bank, (NASDAQ: FFBC), a Cincinnati-headquartered US regional bank.

Mehr erfahren
SCS Computers has been acquired by MAPS Group
Healthcare | TMT

SCS Computers has been acquired by MAPS Group

The private shareholders of SCS Computers, an Italian software company specialized in the healthcare sector, have sold the company to MAPS Group.

Mehr erfahren
GeneTech Inc. has been acquired by Eurofins
Healthcare

GeneTech Inc. has been acquired by Eurofins

Noritsu Koki Co., Ltd. has sold GeneTech Inc. to Eurofins Clinical Testing Holding Lux S.à r.l.

Mehr erfahren